grand opening

Photos: Greentown Labs opens its doors in Houston

Mayor Sylvester Turner, Greentown Labs CEO Emily Reichert, and other guests celebrated the grand opening of Greentown Houston on Earth Day. Photo by Lee Bond/Greentown Labs

On a day that was years in the making, Greentown Labs opened the doors to its new Houston outpost in Midtown yesterday on Earth Day.

The Greentown Houston grand opening event, which was steamed online with limited in-person and outdoor attendance, celebrated the organization's first location outside Somerville, Massachusetts.

"This is a tremendous, tangible milestone not only for Greentown Labs but also for the City of Houston and the energy transition," says Dr. Emily Reichert, CEO of Greentown Labs, in a news release. "Five years ago, climate change wasn't a topic among many conversations in Houston. Things have changed.

"Today, we are so proud to open our second-ever location in the energy capital of the world and we're eager to accelerate the energy transition over the next 10 years," she continues. "Houston is buzzing with incredible climatetech startups, world-leading energy organizations, and a thriving investment community. At Greentown Houston, we aim to bring the ecosystem together and collaborate toward our decarbonized future."

Missed the event? Click here for some significant overheard moments from the Greentown Houston Grand Opening.

The organization also announced new members to its network of partners, including bp, Intel Corporation, Mitsubishi Heavy Industries, White Deer Energy, Ara Partners, Bechtel Corporation, and Mitsubishi Corporation (Americas).

In addition to corporate partners and inaugural startup members, Mayor Sylvester Turner attended the event and welcomed Greentown to Houston.

"There's no better way to celebrate the first anniversary of the Houston Climate Action Plan than to open Greentown Labs Houston," says Mayor Turner. "Attracting and nurturing the next generation of energy companies is a critical piece of our city's ambition to lead the global energy transition. The Climate Action Plan calls for creating 50 Energy 2.0 companies, and thanks to Greentown Labs, we are already halfway there. We are grateful for Greentown Labs and their partners for helping Houston meet our climate goals and become the energy capital of the future."

The 30 inaugural startups will soon move into space in accordance to social distancing. Take a sneak peek at the new facility in the slideshow below.

Celebrating the grand opening

Photo by Natalie Harms/InnovationMap

The grand opening event was streamed online and welcomed select masked guests in-person and outdoors.


Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News